These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 20452699)
1. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. Yang L; Zhang Y; Wang L; Fan F; Zhu L; Li Z; Ruan X; Huang H; Wang Z; Huang Z; Huang Y; Yan X; Chen Y J Hepatol; 2010 Aug; 53(2):339-47. PubMed ID: 20452699 [TBL] [Abstract][Full Text] [Related]
2. Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. Park S; Choi Y; Um SJ; Yoon SK; Park T J Hepatol; 2011 May; 54(5):984-93. PubMed ID: 21145829 [TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116 [TBL] [Abstract][Full Text] [Related]
4. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Liu LF; Purushotham A; Wendel AA; Belury MA Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064 [TBL] [Abstract][Full Text] [Related]
5. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice. Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386 [TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915 [TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [TBL] [Abstract][Full Text] [Related]
9. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065 [TBL] [Abstract][Full Text] [Related]
10. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899 [TBL] [Abstract][Full Text] [Related]
11. Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. Li J; Huang J; Li JS; Chen H; Huang K; Zheng L J Hepatol; 2012 Apr; 56(4):900-7. PubMed ID: 22173165 [TBL] [Abstract][Full Text] [Related]
12. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952 [TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Kim MH; Kang KS; Lee YS Br J Nutr; 2010 Nov; 104(9):1333-42. PubMed ID: 20687969 [TBL] [Abstract][Full Text] [Related]
15. Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease. Nozaki Y; Fujita K; Yoneda M; Wada K; Shinohara Y; Takahashi H; Kirikoshi H; Inamori M; Kubota K; Saito S; Mizoue T; Masaki N; Nagashima Y; Terauchi Y; Nakajima A J Hepatol; 2009 Sep; 51(3):548-56. PubMed ID: 19596472 [TBL] [Abstract][Full Text] [Related]
16. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115 [TBL] [Abstract][Full Text] [Related]
19. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: roles of hepatic MTP and triglyceride secretion. Gao S; He L; Ding Y; Liu G Biochem Biophys Res Commun; 2010 Aug; 398(4):619-26. PubMed ID: 20510883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]